Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section

A Double Blind Randomised Controlled Trial of Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02714179

Enrollment

Registered

2016-03-21

Start date

2015-05-31

Completion date

2016-01-31

Last updated

2016-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section; Dehiscence

Brief summary

The investigators designed a prospective randomized study to investigate the efficacy of intravenous (IV) preemptive versus preventive paracetamol on postoperative pain scores, patient satisfaction, total morphine consumption and the incidence of morphine-related side effects in patients undergoing cesarean section.

Interventions

DRUGParacetamol was given intravenously in both group at different times

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

38 weeks pregnancy, elective cesarean section. \-

Exclusion criteria

morbid obesity, cardiac failure, depression.

Design outcomes

Primary

Measure	Time frame
Visual analog score (VAS) for pain	24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026